IDEAYA Biosciences IDYA
NASDAQ IDYA
$32.72 +0.97 (+3.04%)
At close: Nov 11, 2026 · 4:00 PM EST

IDEAYA Biosciences (IDYA) Return on Sales [ROS] (2020 - 2026)

Updated

IDEAYA Biosciences' Return on Sales [ROS] was -1343.80% in Q3 2026, down 1395.98 percentage points from 52.18% a year earlier but up 36.93 percentage points from the prior quarter.

Analysis

IDEAYA Biosciences (IDYA) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, IDEAYA Biosciences' Return on Sales [ROS] was -1267.38% through Sep 30, 2026, down 1170.15 percentage points year-over-year; for FY2025, it came in at -72.84%, up 4598.23 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of +108.06 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was -4671.07% in FY2024 (-4096.22 pp), -574.85% in FY2023 (-452.13 pp), -122.72% in FY2022 (+57.19 pp) and -179.91% in FY2021 (+0.99 pp).
  • Quarterly Return on Sales [ROS] has moved between -5730.60% (Q3 2024) and 52.18% (Q3 2025) over five years.
  • Compared with a year earlier, Return on Sales [ROS] was higher in two of the last four quarters, with an average year-over-year change of +1146.51 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q3 2025 (a gain of 5782.78 percentage points); the worst was Q3 2024 (a drop of 5313.50 percentage points).
  • Per Business Quant data, IDYA's Return on Sales [ROS] in the three quarters before Q3 2026 was -1380.73% (Q2 2026), -1654.63% (Q1 2026) and -869.53% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 IDEAYA Biosciences 3.07 Bn 90.55 Mn - -1,343.80%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -1,343.80%
Jun 30, 2026 -1,380.73%
Mar 31, 2026 -1,654.63%
Dec 31, 2025 -869.53%
Sep 30, 2025 52.18%
Dec 31, 2024 -2,059.11%
Sep 30, 2024 -5,730.60%
Jun 30, 2024 -1,600.23%
Mar 31, 2024 -1,026.63%
Dec 31, 2023 -1,068.77%
Sep 30, 2023 -417.09%
Jun 30, 2023 -922.94%
Mar 31, 2023 -333.49%
Dec 31, 2022 -657.46%
Sep 30, 2022 2.22%
Jun 30, 2022 -384.53%
Mar 31, 2022 -125.19%
Dec 31, 2021 -620.16%
Sep 30, 2021 -130.49%
Jun 30, 2021 -126.21%
API Access

IDEAYA Biosciences Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IDYA&period=max&api_key=YOUR_API_KEY